The Nanotechnology Knowledge Transfer Network (NanoKTN) has announced the signing of a service level agreement between Bio Nano Consulting and the School of Pharmacy, University of London.
The agreement will enable Bio Nano Consulting to provide its clients with access to an increased pool of academic experts skilled in the fields of pharmaceutics, pharmacology and drug discovery.
The NanoKTN's primary aim is to encourage collaboration and knowledge transfer between key players in industry, as well as start-ups and small and medium-sized enterprises.
One of the key methods to ensure networking between key market players is to facilitate interactions through event organisation.
By doing this, the NanoKTN supports the UK supply chain and creates economic wealth for UK industry.
The partnership has already enabled Bio Nano Consulting to secure a contract with an undisclosed US-based biotechnology company.
Under the terms of the agreement, Bio Nano Consulting will manage a specific project carried out by scientists at the School of Pharmacy, to formulate a Phase I cancer drug with the goal of making the treatment orally available, rather than delivered intravenously.
Once a successful proof of concept is achieved, the School of Pharmacy will work with the company to take it to late-stage development.
